Evidence map›Paper›PMID 41742888›Full record

ArticleHaematologica2026

Nationwide analysis of acute promyelocytic leukemia: incidence and patient outcomes in Germany.

David Baden, Nadine Wolgast, Leo Ruhnke, Klaus Metzeler, Thomas Beder, Alexander Pohlmann, Sophie Steinhäuser, Jacqueline Müller-Nordhorn, Alexander Katalinic, Maria Teresa Voso and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David BadenDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, 24105 Kiel, Germany; University Cancer Centre Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein. david.baden@uksh.de.
Nadine WolgastDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, 24105 Kiel, Germany; University Cancer Centre Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein.
Leo RuhnkeDepartment of Hematology, University Clinic Carl Gustav Carus, Dresden.
Klaus MetzelerDepartment of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, Comprehensive Cancer Center Central Germany (CCCG), University of Leipzig, Leipzig.
Thomas BederDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, 24105 Kiel, Germany; University Cancer Centre Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein.
Alexander PohlmannDepartment of Medicine A, University Hospital Münster, Münster.
Sophie SteinhäuserDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, 24105 Kiel, Germany; University Cancer Centre Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein.
Jacqueline Müller-NordhornBavarian Cancer Registry, Bavarian Health and Food Safety Authority, Nuremberg.
Alexander KatalinicUniversity Cancer Centre Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel; Institute for Social Medicine and Epidemiology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, 23562 Lübeck.
Maria Teresa VosoDepartment of Biomedicine and Prevention, Tor Vergata University, Rome, Italy; Neuro-Oncohematology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Rome, Italy.
Claudia D BaldusDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, 24105 Kiel, Germany; University Cancer Centre Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein.
Lars FranseckyDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, 24105 Kiel, Germany; University Cancer Centre Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41742888
PMCPMC13482266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.